Home > Journals > Minerva Cardioangiologica > Past Issues > Minerva Cardioangiologica 2008 December;56(6) > Minerva Cardioangiologica 2008 December;56(6):671-92

CURRENT ISSUE
 

JOURNAL TOOLS

eTOC
To subscribe
Submit an article
Recommend to your librarian
 

ARTICLE TOOLS

Reprints
Permissions

 

REVIEWS   

Minerva Cardioangiologica 2008 December;56(6):671-92

Copyright © 2008 EDIZIONI MINERVA MEDICA

Hypertrophic cardiomyopathy: individualized therapy for a heterogeneous disease

Sherrid M. V., Sirak T.

Hypertrophic Cardiomyopathy Program and the Echocardiography Laboratory Division of Cardiology, Department of Medicine St. Luke’s, Roosevelt Hospital Center Columbia University College of Physicians and Surgeons New York City, NY, USA


PDF


It is now 50 years since the modern description of hypertrophic cardiomyopathy (HCM). The initial descriptions foretold the current efforts towards sudden death prevention, alleviation of heart failure symptoms and angina, relief of left ventricular outflow tract obstruction, preparticipation athletic screening, family screening and genetic testing. The authors review the salient features of HCM, focusing on therapeutic strategies to manage its symptoms and attempts to prevent sudden death.

top of page